Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Small improvements in rest and recovery can sometimes help restart momentum
Mistake 4: escalating too quickly The four-week minimum at each dose level is not a suggestion
In Phase II trials, MariTide demonstrated up to approximately 20% average weight loss at 52 weeks in people living with obesity or overweight, without evidence of a plateau, suggesting even greater results with longer treatment
Consent for publication Written informed consent was obtained from the patient for the publication of the present case report and any accompanying images
US$ 24.59
US$ 29.67
US$ 23.75
US$ 26.43
US$ 27.16
